MedPath

Recibio, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The Collection and Application of Autologous Amniotic Fluid At Cesarean Delivery Closure.

Not Applicable
Completed
Conditions
Pregnancy Related
Cesarean Section; Infection
Cesarean Wound Disruption
Interventions
Device: Application of Autologous Amniotic Fluid
First Posted Date
2020-04-24
Last Posted Date
2024-12-13
Lead Sponsor
Recibio, Inc.
Target Recruit Count
20
Registration Number
NCT04359472
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath